Literature DB >> 16468073

Is the Glasgow Coma Scale score protected health information?The effect of new United States regulations (HIPAA) on completion of screening logs in emergency research trials.

Erwin J O Kompanje1, Andrew I R Maas2.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16468073     DOI： 10.1007/s00134-005-0021-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.

Authors:  D Moher; K F Schulz; D G Altman
Journal:  Lancet       Date:  2001-04-14       Impact factor: 79.321

2.  Differences in completion of screening logs between Europe and the United States in an emergency phase III trial resulting from HIPAA requirements.

Authors:  Andrew I R Maas; Erwin J O Kompanje; François J A Slieker; Nino Stocchetti
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

3.  The European Union Directive on Clinical Research: present status of implementation in EU member states' legislations with regard to the incompetent patient.

Authors:  F Lemaire; J Bion; J Blanco; P Damas; C Druml; K Falke; J Kesecioglu; A Larsson; J Mancebo; D Matamis; A Pesenti; J Pimentel; M Ranieri
Journal:  Intensive Care Med       Date:  2005-02-15       Impact factor: 17.440

4.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

Review 5.  From Hippocrates to HIPAA: privacy and confidentiality in emergency medicine--Part I: conceptual, moral, and legal foundations.

Authors:  John C Moskop; Catherine A Marco; Gregory Luke Larkin; Joel M Geiderman; Arthur R Derse
Journal:  Ann Emerg Med       Date:  2005-01       Impact factor: 5.721
  5 in total
  2 in total

1.  Screen failure data in clinical trials: Are screening logs worth it?

Authors:  Jordan J Elm; Yuko Palesch; J Donald Easton; Anne Lindblad; William Barsan; Robert Silbergleit; Robin Conwit; Catherine Dillon; Mary Farrant; Holly Battenhouse; Aaron Perlmutter; S Claiborne Johnston
Journal:  Clin Trials       Date:  2014-06-12       Impact factor: 2.486

2.  'No Time to be Lost!' Ethical considerations on consent for inclusion in emergency pharmacological research in severe traumatic brain injury in the European Union.

Authors:  Erwin J O Kompanje
Journal:  Sci Eng Ethics       Date:  2007-09       Impact factor: 3.525
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.